RESUMO
Human cancer is characterized by complex molecular perturbations leading to variable clinical behavior, often even in single-disease entities. We performed a feasibility study systematically comparing large-scale gene expression profiles with clinical features in human B-cell chronic lymphocytic leukemia (B-CLL). cDNA microarrays were employed to determine the expression levels of 1,024 selected genes in 54 peripheral blood lymphocyte samples obtained from patients with B-CLL. Statistical analyses were applied to correlate the expression profiles with a number of clinical parameters including patient survival and disease staging. We were able to identify genes whose expression levels significantly correlated with patient survival and/or with clinical staging. Most of these genes code either for cell adhesion molecules (L-selectin, integrin-beta2) or for factors inducing cell adhesion molecules (IL-1beta, IL-8, EGR1), suggesting that prognosis of this disease may be related to a defect in lymphocyte trafficking. This report demonstrates the feasibility of a systematic integration of large-scale gene expression profiles with clinical data as a general approach for dissecting human diseases.
Assuntos
DNA Complementar/metabolismo , Proteínas Imediatamente Precoces , Leucemia de Células B/diagnóstico , Leucemia de Células B/genética , Leucemia de Células B/metabolismo , Linfócitos/citologia , Análise de Sequência com Séries de Oligonucleotídeos , Adulto , Idoso , Idoso de 80 Anos ou mais , Antígenos CD18/biossíntese , Adesão Celular , Proteínas de Ligação a DNA/biossíntese , Proteína 1 de Resposta de Crescimento Precoce , Estudos de Viabilidade , Feminino , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Imunofenotipagem , Interleucina-1/biossíntese , Interleucina-8/biossíntese , Selectina L/biossíntese , Leucemia de Células B/mortalidade , Linfócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Plasmídeos/metabolismo , Prognóstico , RNA/metabolismo , Fatores de Tempo , Fatores de Transcrição/biossínteseRESUMO
Interactions between leukocytes and epithelial cells may play a key role in Helicobacter pylori-associated gastric mucosal inflammation. This process is mediated by various cell adhesion molecules. The present study examined the molecular mechanisms leading to H. pylori-induced epithelial cell intercellular adhesion molecule-1 (ICAM-1; also called CD54) expression. Coculture of epithelial cells with cytotoxin-associated gene pathogenicity island-positive (cag PAI(+)) H. pylori strains, but not with a cag PAI(-) strain or H. pylori culture supernatants, resulted in upregulation of steady-state mRNA levels and cell surface expression of ICAM-1. Coculture with H. pylori induced an increase in luciferase activity in cells which were transfected with a luciferase reporter gene linked to the 5'-flanking region of the ICAM-1 gene. H. pylori activated the ICAM-1 promoter via the NF-kappaB binding site. An inducible nuclear protein complex bound to the ICAM-1 NF-kappaB site and was identified as the NF-kappaB p50-p65 heterodimer. H. pylori induced the degradation of IkappaB-alpha, a major cytoplasmic inhibitor of NF-kappaB, and stimulated the expression of IkappaB-alpha mRNA. Pretreatment of epithelial cells with pyrrolidine dithiocarbamate, which blocks NF-kappaB activation, inhibited H. pylori-induced ICAM-1 expression. THP-1 macrophagic cells, peripheral blood mononuclear cells, and purified neutrophils adhered to H. pylori-infected epithelial cells to a greater extent than to uninfected cells. These results show that H. pylori directly induces expression of ICAM-1 on gastric epithelial cells in an NF-kappaB-dependent manner that may support leukocyte attachment during inflammation.
Assuntos
Regulação Bacteriana da Expressão Gênica , Helicobacter pylori/patogenicidade , Molécula 1 de Adesão Intercelular/metabolismo , NF-kappa B/metabolismo , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/microbiologia , Antineoplásicos/farmacologia , Aderência Bacteriana , Northern Blotting , Western Blotting , Adesão Celular , Técnicas de Cocultura , Relação Dose-Resposta a Droga , Células Epiteliais/imunologia , Células Epiteliais/metabolismo , Citometria de Fluxo , Deleção de Genes , Humanos , Molécula 1 de Adesão Intercelular/genética , Molécula 1 de Adesão Intercelular/imunologia , Cinética , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/imunologia , Mutagênese , Regiões Promotoras Genéticas , Pirrolidinas/farmacologia , Neoplasias Gástricas/imunologia , Tiocarbamatos/farmacologia , Fatores de Tempo , Células Tumorais Cultivadas , Regulação para CimaRESUMO
Growth factor receptor tyrosine kinases (RTK) have been implicated in tumor growth, metastasis and angiogenesis, and are thus considered promising targets for therapeutic intervention in malignant diseases. We present a novel drug discovery strategy to find inhibitors of RTKs based on comparative screening of compound libraries employing functional cellular assays. Cell lines stably expressing HER2 and the receptors for hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), insulin-like growth factor-I (IGF-I) and epidermal growth factor (EGF) have been established. All cell lines are based on FDC-P1, a murine myeloid progenitor cell line which allows a direct comparison of results obtained in primary screens. In addition, the same cell lines are suitable for compound optimization and for animal studies. Using this strategy we report the identification of promising lead candidates for further drug development which are highly selective, non-cytotoxic and cell permeable with potencies in the low micromolar range.
Assuntos
Antineoplásicos/farmacologia , Inibidores Enzimáticos/farmacologia , Receptores Proteína Tirosina Quinases/antagonistas & inibidores , Animais , Antineoplásicos/uso terapêutico , Linhagem Celular , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Camundongos , Camundongos Nus , Transplante de Neoplasias , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/enzimologia , Receptores Proteína Tirosina Quinases/metabolismo , Receptores de Fatores de Crescimento/metabolismoRESUMO
Recent advances in technology, especially the merger between molecular biology, automation technology and computer science, are rapidly changing the manner in which pharmaceutical companies will discover new drug targets and develop new therapeutic drugs. One example of such a merger between different disciplines has been the development of technology platforms, such as cDNA microarrays and oligonucleotide arrays, allowing the generation of comprehensive gene expression profiles in a previously insurmountable throughput. Hereby, the major limitation is currently shifting from the efficient generation of biological information to the extraction of biological knowledge. However, given the foreseeable developments in data mining technologies and diverse computational biology tools, it can be anticipated that this information will foster the effectiveness to develop new and hopefully better drugs.
Assuntos
Biologia Computacional/métodos , Desenho de Fármacos , Descoberta de Drogas , Perfilação da Expressão Gênica/métodos , Tecnologia Farmacêutica/métodos , Análise por Conglomerados , Humanos , Análise de Sequência com Séries de Oligonucleotídeos/métodos , Reprodutibilidade dos Testes , Tecnologia Farmacêutica/tendênciasRESUMO
Human intercellular adhesion molecule-1 (ICAM-1) plays an important role in immune responses as the major specific ligand for the beta2-integrins LFA-1 and Mac-1. During the inflammatory process, ICAM-1 expression is stimulated by various proinflammatory cytokines. We have examined the mechanisms of transcriptional control involved in the stimulation of ICAM-1 gene expression by tumor necrosis factor-alpha (TNF-alpha) and by the nuclear factor-kappaB (NF-kappaB) family of transcription factors in the Ad5-transformed human embryonal kidney cell line 293. A proximal site (5'-TTGGAAATTCC-3') mapping at position -228 from the ATG and known to mediate TNF-alpha responsiveness in endothelial cells is also critical for TNF-alpha responsiveness in 293 cells. However, unlike endothelial cells, electrophoretic mobility shift assays, using whole-cell extracts prepared from TNF-alpha-treated cells, showed that TNF-alpha induces the formation of a specific kappaB binding complex, mainly composed of NF-kappaB subunits RelA and c-Rel. Electrophoretic mobility shift assays done with 293 cells transfected with p50, p65, or both subunits showed that p50 only has a weak ability to bind the proximal ICAM-1 NF-kappaB site. Another element exhibiting sequence homology with NF-kappaB binding sites and located at position -540 relative to the mRNA cap site was found to be involved in the basal activity of the ICAM-1 promoter, is not required for TNF-alpha responsiveness, and does not bind NF-kappaB subunits. Whereas transactivation of the ICAM-1 promoter by p65 requires the proximal NF-kappaB site, deletion mutant analysis showed that p50 and, to a greater extent, p52 transactivate reporter plasmids lacking NF-kappaB sites, suggesting the presence of other p50/p52 responsive element(s).
Assuntos
Proteínas de Ligação ao Cálcio , Molécula 1 de Adesão Intercelular/genética , Glicoproteínas de Membrana/metabolismo , NF-kappa B/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Fator de Necrose Tumoral alfa/farmacologia , Células Cultivadas , Regulação da Expressão Gênica , Genes Reporter , Humanos , Rim/citologia , Subunidade p50 de NF-kappa B , Proteínas Proto-Oncogênicas c-rel , Sinaptotagmina I , Sinaptotagminas , Fatores de Transcrição/metabolismo , Ativação Transcricional , TransfecçãoRESUMO
Human intercellular adhesion molecule-1 (ICAM-1), a transmembrane glycoprotein that functions as a ligand for lymphocyte function-associated antigen-1, plays an important role in mediating cell-cell interactions in inflammatory reactions. It is induced by proinflammatory cytokines such as interleukin-1, tumor necrosis factor-alpha or interferon-gamma, as well as by phorbol esters, retinoic acid and lipopolysaccharide. Furthermore, ICAM-1 is upregulated by interleukin-6, which suggests that it belongs to the family of acute phase response genes. Investigation of the 5'-regulatory region of the human ICAM-1 gene revealed sequence motifs for a variety of transcription factors implicated in transcriptional regulation. This review summarizes the current knowledge of the transcriptional regulation of the human ICAM-1 gene.
Assuntos
Regulação da Expressão Gênica/imunologia , Molécula 1 de Adesão Intercelular/genética , Transcrição Gênica/imunologia , Sequência de Bases , Humanos , Dados de Sequência MolecularRESUMO
Human intercellular adhesion molecule-1 (ICAM-1), a specific ligand for the leukocyte-function associated antigen-1 and for Mac-1, plays an important role in immune responses. ICAM-1 expression is regulated by various proinflammatory cytokines, phorbol myristate acetate, and retinoic acid. In this study, we investigated the mechanisms of transcriptional control involved in the stimulation of ICAM-1 gene expression by retinoic acid in Cos-1 cells. Deletion mutant analysis provided evidence that a region located between -393 and -176 from the translational start site is critical to retinoic acid stimulation of luciferase activity. This region harbors the consensus sequence for a retinoic acid-responsive element (RARE) 5'-GGGTCATCGCCCTGCCA-3'. The Smal(-270)/Smal (-178) fragment containing this element conferred appropriate retinoic acid responsiveness to an enhancerless SV40 promoter. Cotransfection of expression vectors encoding the retinoic acid receptor alpha, beta, or gamma and retinoid X receptor alpha with reporter plasmids harboring the putative RARE demonstrated that the ICAM-1 gene is regulated by retinoic acid in a retinoic acid receptor beta/retinoid X receptor alpha-dependent fashion. Electrophoretic mobility shift assays showed that ICAM-1 and ADH3 RARE, a well-characterized RARE, display the same band shift pattern, bind retinoic acid receptor beta and retinoid X receptor alpha, and are mutually competitive.
Assuntos
Molécula 1 de Adesão Intercelular/genética , Proteínas Nucleares/farmacologia , Receptores do Ácido Retinoico/genética , Fatores de Transcrição/genética , Ativação Transcricional/efeitos dos fármacos , Sequência de Bases , Ligação Competitiva , Células Cultivadas , Sequência Consenso , Eletroforese em Gel de Poliacrilamida , Humanos , Molécula 1 de Adesão Intercelular/biossíntese , Dados de Sequência Molecular , Proteínas Nucleares/genética , Regiões Promotoras Genéticas , Receptores X de Retinoides , Acetato de Tetradecanoilforbol/farmacologia , Tretinoína/farmacologiaRESUMO
The neurokinin receptor family is known to modulate phospholipase C activity. In order to find new compounds modulating the activity of these receptors we have developed a cellular screening system that measures the biological activity of receptors coupled to the IP3/DAG signal transduction pathway via the transcriptional activation of a reporter gene. For the establishment of neurokinin test cell lines the reporter cell line A20, stably transformed with the luciferase gene under the control of a promoter containing TPA response elements (TRE), which did not respond to neurokinin agonists, was used. Stable test cell lines were developed by transfecting the reporter cell line A20 with the genes for the human neurokinin receptors NK1, NK2 or NK3, respectively. In these cell lines, expression of luciferase was inducible by substance P, neurokinin A and neurokinin B, respectively. The order of potency of the three neurokinins substance P, neurokinin A and neurokinin B was consistent with published data and results from ligand binding studies performed with the NK1 and NK2 test cell lines. The agonistic effect of the neurokinins could be inhibited in a dose-dependent manner by simultaneous addition of neurokininspecific antagonists like the non-peptide antagonists CP-99,994 and SR 48968.
Assuntos
Bioensaio/métodos , Receptores da Neurocinina-1/metabolismo , Receptores da Neurocinina-2/metabolismo , Receptores da Neurocinina-3/metabolismo , Linhagem Celular , Diglicerídeos/metabolismo , Genes Reporter , Humanos , Inositol 1,4,5-Trifosfato/metabolismo , Luciferases/genética , Ensaio Radioligante , Receptores da Neurocinina-1/análise , Receptores da Neurocinina-1/genética , Receptores da Neurocinina-2/análise , Receptores da Neurocinina-2/genética , Receptores da Neurocinina-3/análise , Receptores da Neurocinina-3/genética , Transdução de Sinais , Taquicininas/metabolismo , Taquicininas/farmacologia , TransfecçãoRESUMO
Human intercellular adhesion molecule-1 (ICAM-1), a specific ligand for the lymphocyte-function-associated antigen-1, plays an important role in immune responses. ICAM-1 expression is regulated by various proinflammatory cytokines, by PMA, and by retinoic acid. In this study, we have investigated the mechanisms of transcriptional control involved in the stimulation of ICAM-1 gene expression by retinoic acid in SK-N-SH cells. Northern-blot analysis demonstrated that ICAM-1 mRNA is maximally induced at 24 hr, suggesting that it is not an early-response gene with respect to retinoic-acid responsiveness, whereas the retinoic acid receptor-beta mRNA level was maximal 12 hr following retinoic acid treatment. To analyze the 5'-regulatory region of the ICAM-1 gene, an EcoRI/SaII fragment spanning the first 1.3 kb upstream of the translational start site was used to direct the expression of a linked luciferase reporter gene in transient transfection assays in SK-N-SH cells. A 24-hr treatment of transfected cells with 10 microM retinoic acid resulted in a 10- to 13-fold increase in luciferase activity compared with untreated cells. Deletion mutant analysis revealed that a region located between -393 and -176 bp from the translational start site is critical for retinoic acid stimulation of luciferase activity. This region harbors a consensus sequence for a retinoic-acid-responsive element (RARE) homologous to the element found upstream of the alcohol dehydrogenase-3 gene. Co-transfection of expression vectors encoding the retinoic acid receptor-alpha, -beta, or -gamma, with reporter plasmids harboring the putative RARE, confirmed that the ICAM-1 gene is regulated by retinoic acid in a retinoic acid receptor-dependent fashion.
Assuntos
Moléculas de Adesão Celular/metabolismo , Regulação da Expressão Gênica , Tretinoína/farmacologia , Sequência de Bases , Moléculas de Adesão Celular/genética , Células Cultivadas , Sequência Consenso , Análise Mutacional de DNA , Humanos , Molécula 1 de Adesão Intercelular , Dados de Sequência Molecular , Regiões Promotoras Genéticas , RNA Mensageiro/análise , Receptores do Ácido Retinoico/metabolismo , Sequências Reguladoras de Ácido Nucleico , Fatores de Tempo , Transcrição Gênica , TransfecçãoRESUMO
We have constructed a Xenopus oocyte cDNA library in a Saccharomyces cerevisiae expression vector and used this library to isolate genes that can function in yeast cells to suppress the temperature sensitive [corrected] defect of the cdc15 mutation. Two maternally expressed Xenopus cDNAs which fulfill these conditions have been isolated. One of these clones encodes Xenopus N-ras. In contrast to the yeast RAS genes, Xenopus N-ras rescues the cdc15 mutation. Moreover, overexpression of Xenopus N-ras in S. cerevisiae does not activate the RAS-cyclic AMP (cAMP) pathway; rather, it results in decreased levels of intracellular cAMP in both mutant cdc15 and wild-type cells. Furthermore, we show that lowering cAMP levels is sufficient to allow cells with a nonfunctional Cdc15 protein to complete the mitotic cycle. These results suggest that a key step of the cell cycle is dependent upon a phosphorylation event catalyzed by cAMP-dependent protein kinase. The second clone, beta TrCP (beta-transducin repeat-containing protein), encodes a protein of 518 amino acids that shows significant homology to the beta subunits of G proteins in its C-terminal half. In this region, beta Trcp is composed of seven beta-transducin repeats. beta TrCP is not a functional homolog of S. cerevisiae CDC20, a cell cycle gene that also contains beta-transducin repeats and suppresses the cdc15 mutation.
Assuntos
Proteínas de Ciclo Celular , Ciclo Celular , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/metabolismo , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Saccharomyces cerevisiae/citologia , Transducina/metabolismo , Proteínas de Xenopus , Anáfase , Animais , Sequência de Bases , Clonagem Molecular , AMP Cíclico/metabolismo , DNA/genética , Proteínas Fúngicas/genética , Expressão Gênica , Genes , Teste de Complementação Genética , Vetores Genéticos , Dados de Sequência Molecular , Mutagênese Insercional , Oligonucleotídeos/química , RNA Mensageiro/genética , Saccharomyces cerevisiae/genética , Alinhamento de Sequência , Xenopus laevis/genética , Proteínas Contendo Repetições de beta-TransducinaRESUMO
A large number of G-protein coupled receptors are known to modulate adenylyl cyclase activity. In order to find new compounds modulating the activity of specific receptor subtypes we developed a cellular screening system that measures the biological activity of drugs acting on receptors rather than merely their binding characteristics. The activity of the receptor coupling to the cAMP signal transduction pathway was measured via transcriptional activation of a reporter gene. A chinese hamster ovary cell line was stably transformed with a reporter plasmid containing the firefly luciferase gene under the transcriptional control of multiple cAMP responsive elements (CRE). This CRE reporter cell line exhibited 20 to 30-fold induction of luciferase activity upon stimulation of adenylyl cyclase with forskolin, but did not respond to dopamine agonists. Stable test cell lines were developed by transfecting reporter cell lines with human dopamine D1 and D5 receptor genes, respectively. Treatment of these test cell lines with dopamine receptor agonists and antagonists modulated the luciferase expression in a dose-dependent manner. The rank of potency of dopamine receptor agonists and antagonists was in agreement with reported data obtained from binding studies. The non-isotopic assay can be performed in microtiter plate format and is far less work intensive than the determination of adenylyl cyclase activity by direct cAMP measurement. This technology could also be utilized for discovery of new classes of compounds, e.g. allosteric effectors or non competitive ligands.
Assuntos
AMP Cíclico/fisiologia , Luciferases/genética , Receptores de Dopamina D1/fisiologia , Receptores Dopaminérgicos/fisiologia , Animais , Sequência de Bases , Células CHO , Cricetinae , Humanos , Luciferases/análise , Dados de Sequência Molecular , Plasmídeos/genética , Receptores de Dopamina D5 , Proteínas Recombinantes , Sequências Reguladoras de Ácido Nucleico , Transfecção/métodosRESUMO
A functional cellular assay system was developed for the detection of substances modulating the activity of G protein-coupled receptors, linked to the phospholipase C second messenger system. The human adenocarcinoma cell line A549 was transformed with the Photinus pyralis luciferase gene under the control of the ICAM-1 gene 5'regulatory region and, subsequently, stably transfected with the human neurokinin 2 (NK2) receptor gene. The ICAM-1 promoter is known to be inducible via the phospholipase C signal transduction pathway. In this NK2 receptor test cell line, expression of luciferase was inducible by neurokinin A and other NK2-specific agonists. The order of potency of the three neurokinins substance P, neurokinin A and neuromedin K was consistent with published data and results from ligand binding studies performed with the same NK2 test cell line. The agonistic effect of neurokinin A could be inhibited in a dose-dependent manner by simultaneous addition of NK2-specific antagonists or protein kinase C-inhibitors. Similarly, a stable test cell line expressing the human serotonin 2 receptor was established. Agonist-induced luciferase expression in this cell line was abolished in the presence of 5-HT2-specific antagonists. These cellular assay systems can be employed for the identification of competitive, non-competitive and allosteric modulators of the NK2 and the 5-HT2 receptor, and they represent prototypes for analogous test cell lines for other phospholipase C-coupled receptors.
Assuntos
Proteínas de Ligação ao GTP/metabolismo , Receptores da Neurocinina-2/análise , Receptores de Serotonina/análise , Bioensaio/métodos , Linhagem Celular , Regulação da Expressão Gênica/efeitos dos fármacos , Genes Reporter , Humanos , Molécula 1 de Adesão Intercelular/genética , Luciferases/genética , Neurocinina A/farmacologia , Neurocinina B/farmacologia , Fosfatidilinositóis/metabolismo , Sistemas do Segundo Mensageiro , Substância P/farmacologia , Transfecção , Fosfolipases Tipo C/metabolismoRESUMO
Human intercellular adhesion molecule-1 (ICAM-1), a specific ligand for the lymphocyte function-associated Ag-1 (LFA-1), plays an important role in leukocyte-endothelial cell interactions. It is induced by proinflammatory cytokines such as IL-1, TNF-alpha, or IFN-gamma. However, little is known concerning the intracellular regulatory mechanisms which trigger ICAM-1 up-regulation. In order to study potential regulatory elements involved in ICAM-1 induction we have cloned the human ICAM-1 gene and 5 kb of its 5'-regulatory region. The sequence of the cDNA was found to be distributed over seven exons separated by six introns, whereby each of the five extracellular Ig-like domains of ICAM-1 is encoded by its own exon. The upstream sequence harbors a number of sequence motifs implicated in the regulation and expression of eukaryotic genes, including binding sites for the transcription factors SP-1, AP-1, and NF-kB. Primer extension and S1 nuclease analysis revealed two transcription initiation sites 319 bp and 41 bp upstream of the translation start site. Consensus TATA boxes were found at the expected positions about 25 bp upstream of both start sites. Reverse transcriptase polymerase chain reaction showed differential use of the two TATA boxes in A549 and HS913T cells. Both RNA seem to code for the same for of ICAM-1 protein. For regulation studies a 1.3-kb EcoRI/SalI fragment of the 5'-flanking region was used to promote transcription of a linked luciferase reporter gene in transient-transfection assays in A549 and HS913T cells. Treatment of A549 cells with IL-1 or TNF-alpha resulted in a two- or fourfold increase in luciferase activity. Furthermore, a sixfold induction could be achieved after treatment with the phorbol ester PMA. In contrast, agents that increase intracellular cAMP levels did not induce luciferase activity. Northern blot analysis was used to investigate the kinetics of ICAM-1 mRNA synthesis upon induction with TNF-alpha and PMA. These data suggest that the up-regulation of ICAM-1 by cytokines occurs at least partly at the transcriptional level. Deletion analysis of the 1.3-kb fragment of the 5'-flanking region revealed sequences responsible for promotion and inhibition of transcription. In particular, two functionally distinct regions have been characterized: a short fragment containing an NF-kB binding site has been shown to function as an activator, followed immediately downstream by a sequence acting as a silencer element. Therefore, ICAM-1 gene expression seems to be modulated by multiple cis-acting elements.
Assuntos
Moléculas de Adesão Celular/genética , Clonagem Molecular , Regulação da Expressão Gênica/efeitos dos fármacos , Interferon gama/farmacologia , Interleucina-1/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Fator de Necrose Tumoral alfa/farmacologia , Sequência de Bases , Deleção Cromossômica , Dexametasona/farmacologia , Humanos , Molécula 1 de Adesão Intercelular , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Regiões Promotoras Genéticas , Transcrição Gênica/efeitos dos fármacosRESUMO
cDNA clones encoding the human erythrocyte band 7 membrane protein were isolated by immunoscreening from bone marrow and HeLa cell lambda gt 11 cDNA libraries, and their nucleotide sequences were determined. HeLa- and bone marrow cell-derived sequences were identical, except for one nucleotide; the deduced sequence of 287 amino acids was confirmed by sequence identity with peptides of the erythroid protein. Structure analysis assigned band 7 protein to the type Ib transmembrane proteins.
Assuntos
Proteínas Sanguíneas/genética , Membrana Eritrocítica/química , Proteínas de Membrana/genética , Sequência de Aminoácidos , Sequência de Bases , Proteínas Sanguíneas/química , Células da Medula Óssea , Células Cultivadas , Clonagem Molecular , Células HeLa , Humanos , Proteínas de Membrana/química , Dados de Sequência Molecular , Conformação ProteicaRESUMO
We have determined the complete cDNA sequence of rat plectin from a number of well-characterized overlapping lambda gt11 clones. The 4,140-residue predicted amino acid sequence (466,481 D) is consistent with a three-domain structural model in which a long central rod domain, having mainly an alpha-helical coiled coil conformation, is flanked by globular NH2- and COOH-terminal domains. The plectin sequence has a number of repeating motifs. The rod domain has five subregions approximately 200-residues long in which there is a strong repeat in the charged amino acids at 10.4 residues that may be involved in association between plectin molecules. The globular COOH-terminal domain has a prominent six-fold tandem repeat, with each repeat having a strongly conserved central region based on nine tandem repeats of a 19-residue motif. The plectin sequence has several marked similarities to that of desmoplakin (Green, K. J., D. A. D. Parry, P. M. Steinert, M. L. A. Virata, R. M. Wagner, B. D. Angst, and L.A. Nilles. 1990. J. Biol. Chem. 265:2,603-2,612), which has a shorter coiled-coil rod domain with a similar 10.4 residue charge periodicity and a COOH-terminal globular domain with three tandem repeats homologous to the six found in plectin. The plectin sequence also has homologies to that of the bullous pemphigoid antigen. Northern blot analysis indicated that there is a significant degree of conservation of plectin genes between rat, human, and chicken and that, as shown previously at the protein level, plectin has a wide tissue distribution. There appeared to be a single rat plectin gene that gave rise to a 15-kb message. Expression of polypeptides encoded by defined fragments of plectin cDNA in E. coli has also been used to localize the epitopes of a range of monoclonal and serum antibodies. This enabled us to tentatively map a sequence involved in plectin-vimentin and plectin-lamin B interactions to a restricted region of the rod domain.
Assuntos
Proteínas de Transporte , Colágeno , Proteínas de Filamentos Intermediários , Proteínas do Tecido Nervoso , Colágenos não Fibrilares , Proteínas/química , Sequência de Aminoácidos , Animais , Autoantígenos/química , Autoantígenos/genética , Sequência de Bases , Clonagem Molecular , Proteínas do Citoesqueleto/química , Proteínas do Citoesqueleto/genética , DNA/genética , Desmoplaquinas , Desmossomos , Distonina , Humanos , Dados de Sequência Molecular , Peso Molecular , Penfigoide Bolhoso/imunologia , Plectina , Conformação Proteica , Proteínas/genética , RNA Mensageiro/genética , Ratos , Homologia de Sequência do Ácido Nucleico , Células Tumorais Cultivadas , Colágeno Tipo XVIIRESUMO
Tumor necrosis factor-alpha (TNF-alpha), a protein released by activated macrophages, is involved in a wide variety of human diseases including septic shock, cachexia, and chronic inflammation. TNF binding protein (TNF-BP), a glycoprotein with high affinity to TNF-alpha isolated from urine, acts as an inhibitor of TNF-alpha by competing with the cell-surface TNF receptor. We report here the partial amino acid sequencing of human TNF-BP as well as the isolation, sequence, and expression of cDNA clones encoding a human and rat TNF receptor. The calculated Mr of the mature human and rat TNF receptor chains is 47,526 and 48,072, respectively. The extracellular ligand binding domain represents the soluble TNF-BP which is released by proteolytic cleavage. TNF-BP contains 24 cysteine residues and three potential N-glycosylation sites and shows sequence homology to the extracellular portions of TNF-R p80 chain and nerve growth factor receptor. Transfection of the human TNF receptor cDNA into mammalian cells resulted in increased binding capacity for TNF-alpha and increased reactivity with a monoclonal antibody directed against the human TNF receptor chain p60. When a stop codon was introduced into the cDNA at the site corresponding to the carboxyl terminus of TNF-BP, transfected cells secreted a protein that reacted with antibodies raised against natural TNF-BP.
Assuntos
Expressão Gênica , Receptores de Superfície Celular/genética , Fator de Necrose Tumoral alfa/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Northern Blotting , Clonagem Molecular , DNA/genética , DNA/isolamento & purificação , Humanos , Dados de Sequência Molecular , Plasmídeos , Poli A/análise , Reação em Cadeia da Polimerase , RNA/análise , RNA Mensageiro , Ratos , Receptores de Fator de Crescimento Neural , Receptores do Fator de Necrose Tumoral , Transfecção , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Rhinoviruses belong to the picornavirus family and cause about 50% of common colds. Most rhinoviruses and some coxsackie viruses share a common receptor on human cells. The glycoprotein intercellular adhesion molecule-1 (ICAM-1) has recently been identified as the cellular receptor for the subgroup of rhinoviruses known as the major groups. ICAM-1 is a member of the immunoglobulin supergene family and is a ligand for lymphocyte function-associated antigen-1 (LFA-1); these ICAM-1/LFA-1 interactions are critical to many cell adhesion processes involved in the immunological response. Because anti-ICAM-1 antibodies can block binding of major-group rhinoviruses to cells, we considered that antagonism of virus-receptor interaction might be a way of preventing rhinovirus infection. We have constructed and purified a soluble form of the ICAM-1 molecule, which is normally membrane-bound, and demonstrated that it is a potent and specific inhibitor of rhinovirus infection.
Assuntos
Antivirais , Moléculas de Adesão Celular/farmacologia , Receptores Virais/efeitos dos fármacos , Rhinovirus/efeitos dos fármacos , Sequência de Aminoácidos , Sequência de Bases , Efeito Citopatogênico Viral/efeitos dos fármacos , Molécula 1 de Adesão Intercelular , Dados de Sequência Molecular , Picornaviridae/efeitos dos fármacos , Proteínas Recombinantes/farmacologia , Simplexvirus/efeitos dos fármacos , SolubilidadeRESUMO
Based on sequence information from tryptic peptides an almost full-size cDNA coding for the human vascular anticoagulant was isolated from a placental cDNA library and sequenced. The coding region was cloned into an Escherichia coli expression vector and the protein expressed at high levels. The recombinant protein was purified and found to be indistinguishable from its natural counterpart in several biological assays.
Assuntos
Coagulação Sanguínea/efeitos dos fármacos , Clonagem Molecular , Peptídeos/genética , Sequência de Aminoácidos , Anexinas , Sequência de Bases , Cálcio/metabolismo , DNA/análise , Eletroforese em Gel de Poliacrilamida , Humanos , Dados de Sequência Molecular , Peptídeos/metabolismo , Peptídeos/farmacologia , Fosfolipídeos/metabolismo , Placenta/análise , RNA/análiseRESUMO
Intercellular adhesion molecule 1 (ICAM-1) is a 90 kd inducible surface glycoprotein that promotes adhesion in immunological and inflammatory reactions. ICAM-1 is a ligand of lymphocyte function-associated antigen-1 (LFA-1), an alpha beta complex that is a member of the integrin family of cell-cell and cell-matrix receptors. ICAM-1 is encoded by an inducible 3.3 kb mRNA. The amino acid sequence specifies an integral membrane protein with an extracellular domain of 453 residues containing five immunoglobulin-like domains. Highest homology is found with neural cell adhesion molecule (NCAM) and myelin-associated glycoprotein (MAG), which also contain five Ig-like domains. NCAM and MAG are nervous system adhesion molecules, but unlike ICAM-1, NCAM is homophilic. The ICAM-1 and LFA-1 interaction is heterophilic and unusual in that it is between members of the immunoglobulin and intergrin families. Unlike other integrin ligands, ICAM-1 does not contain an RGD sequence.
Assuntos
Antígenos de Superfície/genética , Genes de Imunoglobulinas , Genes , Imunoglobulinas/genética , Glicoproteínas de Membrana/genética , Sequência de Aminoácidos , Sequência de Bases , Moléculas de Adesão Celular , Clonagem Molecular , Humanos , Leucemia de Células Pilosas/genética , Leucemia de Células Pilosas/imunologia , Linfócitos/imunologia , Linfócitos/metabolismo , Dados de Sequência Molecular , RNA Mensageiro/genéticaRESUMO
We have cloned a full-length putative rat pancreatic lysophospholipase cDNA by an improved mRNA isolation method and cDNA cloning strategy. These new methods allow the construction of a cDNA library from the adult rat pancreas in which the majority of recombinant clones contained complete sequences for the corresponding mRNAs. A previously recognized but unidentified long and relatively rare cDNA clone containing the entire sequence from the cap site at the 5' end to the poly(A) tail at the 3' end of the mRNA was isolated by single-step screening of the library. The size, amino acid composition, and the activity of the protein expressed in heterologous cells strongly suggest this mRNA codes for lysophospholipase [Van den Bosch, H., Aarsman, A. J., DeJong, G. N., & Van Deenen, L. M. (1973) Biochim. Biophys. Acta 296, 94-104].